Bispecific T cell activating antigen binding molecules

Patent metadata

Field	Value
Publication number	US-10611840-B2
Application number	US-201815879040-A
Country	US
Kind code	B2
Filing date	Jan 24, 2018
Priority date	Aug 4, 2014
Publication date	Apr 7, 2020
Grant date	Apr 7, 2020

Abstract

The present invention generally relates to novel bispecific antigen binding molecules for T cell activation and re-direction to specific target cells. In addition, the present invention relates to polynucleotides encoding such bispecific antigen binding molecules, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the bispecific antigen binding molecules of the invention, and to methods of using these bispecific antigen binding molecules in the treatment of disease.

First claim

What is claimed is:

1. Isolated polynucleotides encoding a T cell activating bispecific antigen-binding molecule comprising:
(a) a first Fab molecule which specifically binds to a first antigen;
(b) a second Fab molecule which specifically binds to a second antigen, wherein the variable domains VL and VH of the Fab light chain and the Fab heavy chain are replaced by each other;
(c) a third Fab molecule which specifically binds to the first antigen; and
(d) an Fc domain composed of a first and a second CH2-CH3 domain capable of stable association, wherein:
(i) the first antigen is CD20 and the second antigen is CD3;
(ii) the first Fab molecule under (a) and the third Fab molecule under (c) each comprise the heavy chain complementarity determining region (CDR) 1 of SEQ ID NO: 46, the heavy chain CDR 2 of SEQ ID NO: 47, the heavy chain CDR 3 of SEQ ID NO: 48, the light chain CDR 1 of SEQ ID NO: 49, the light chain CDR 2 of SEQ ID NO: 50 and the light chain CDR 3 of SEQ ID NO: 51, and the second Fab molecule under (b) comprises the heavy chain CDR 1 of SEQ ID NO: 4, the heavy chain CDR 2 of SEQ ID NO: 5, the heavy chain CDR 3 of SEQ ID NO: 6, the light chain CDR 1 of SEQ ID NO: 8, the light chain CDR 2 of SEQ ID NO: 9 and the light chain CDR 3 of SEQ ID NO: 10;
(iii) in the constant domain CL of the first Fab molecule under (a) and the third Fab molecule under (c) the amino acid at position 124 is substituted by lysine (K) (numbering according to Kabat) and the amino acid at position 123 is substituted by lysine (K) or arginine (R) (numbering according to Kabat), and wherein in the constant domain CH1 of the first Fab molecule under (a) and the third Fab molecule under (c) the amino acid at position 147 is substituted by glutamic acid (E) (numbering according to Kabat EU index) and the amino acid at position 213 is substituted by glutamic acid (E) (numbering according to Kabat EU index); and
(iv) the first Fab molecule under (a) is fused at the C-terminus of the Fab heavy chain to the N-terminus of the Fab heavy chain of the second Fab molecule under (b), and the second Fab molecule under (b) and the third Fab molecule under (c) are each fused at the C-terminus of the Fab heavy chain to the N-terminus of the Fc domain under (d).

2. A host cell comprising the two or more polynucleotides of claim 1 .

3. A method of producing a T cell activating bispecific antigen-binding molecule capable of specific binding to CD3 and a target cell antigen, comprising the steps of:
(a) culturing the host cell of claim 2 under conditions suitable for the expression of the T cell activating bispecific antigen-binding molecule; and
(b) recovering the T cell activating bispecific antigen-binding molecule.

4. The two or more isolated polynucleotides of claim 1 , wherein the CD3 is CD3 epsilon.

5. The two or more isolated polynucleotides of claim 1 , wherein the amino acid at position 123 is substituted by arginine (R) (numbering according to Kabat).

Assignees

• Hoffmann La Roche

Inventors

• Ast Oliver
• Bacac Marina
• Imhof-Jung Sabine
• Neumann Christiane
• Klein Christian
• Klostermann Stefan
• Molhoj Michael
• Regula Joerg Thomas
• Schaefer Wolfgang
• Umana Pablo

Classifications

• C07K2317/21

  from primates, e.g. man · CPC title

• C07K2317/51

  Complete heavy chain or Fd fragment, i.e. VH + CH1 · CPC title

• C07K2317/54

  F(ab')2 · CPC title

• C07K2317/526

  CH3 domain · CPC title

• C07K2317/66

  comprising a swap of domains, e.g. CH3-CH2, VH-CL or VL-CH1 · CPC title